These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 2264421

  • 1. [Effect of 2 different forms of chemotherapy on remission in patients with advanced ovarian cancer].
    Krommer K, Keller G, Csaba I, Garadnay B, Göcze P.
    Zentralbl Gynakol; 1990; 112(17):1105-10. PubMed ID: 2264421
    [Abstract] [Full Text] [Related]

  • 2. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S, Yeap B, Vogl S, Carbone P.
    Cancer; 1996 Feb 15; 77(4):733-42. PubMed ID: 8616766
    [Abstract] [Full Text] [Related]

  • 3. [Results of the first Austrian multicenter ovarian cancer study: prospective randomized comparison of sequential chemotherapy (adriamycin/cisplatin--vincristine/cyclophosphamide--methotrexate) with 2 standard protocols (adriamycin/cyclophosphamide or adriamycin/cisplatin) in stage III and IV patients].
    Salzer H, Gitsch E, Dittrich C, Sevelda P, Karrer K, Schemper M, Stempel-Smekal G, Langer M, Wagner G, Rainer H.
    Geburtshilfe Frauenheilkd; 1985 Nov 15; 45(11):761-8. PubMed ID: 3908214
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of advanced ovarian cancer].
    de Gramont A, Krulik M, Pigne A, Brissaud P, Sirinelli A, Hubert D, Zylberait D, Debray J.
    Sem Hop; 1984 Mar 29; 60(14):957-60. PubMed ID: 6326283
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Chemotherapy in 143 advanced epithelial cancers of the ovary. Experience at the Hôtel-Dieu of Quebec and Hôpital Saint-Antoine (Paris)].
    de Gramont A, Drolet Y, Louvet C, Dray C, Krulik M, Pigné A, Lavoie A, Painchaud M, Blouin R, Tessier C.
    J Gynecol Obstet Biol Reprod (Paris); 1986 Mar 29; 15(1):105-9. PubMed ID: 3084619
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ, Lele SB.
    Cancer Treat Rep; 1984 Dec 29; 68(12):1433-8. PubMed ID: 6439408
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of patients with advanced ovarian cancer at the Gynecological Clinic of Pécs Medical University].
    Krommer K.
    Orv Hetil; 1992 May 10; 133(19):1151-8. PubMed ID: 1584596
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.